Get the tools used by (smart)2 investors.

Inozyme Pharma IncNASDAQGS:INZY

United States / Healthcare / Biotechnology

Income Statement
Balance Sheet
Cash Flow Statement
EBITDA Reconciliation
Net Income Reconciliation
Forecasts
Valuation Ratios
Fiscal Years
Fiscal Half
Fiscal Quarters
Year To Date
Latest Twelve Months
Ascending
Descending
3 Years
5 Years
10 Years
Millions
Billions
Thousands
Ones
Standard Size
Common Size
Growth Rate
2020-05-31
FY-4
2021-05-31
FY-3
2022-05-31
FY-2
2023-05-31
FY-1
2024-05-31
FY
Revenue
7,085.1
7,116.3
7,854.5
8,815.8
9,596.6
Revenue Growth (YoY)
2.8%
0.4%
10.4%
12.2%
8.9%
Cost of Revenues
-3,851.4
-3,801.7
-4,222.2
-4,642.4
-4,910.2
Gross Profit
3,233.7
3,314.7
3,632.2
4,173.4
4,686.4
Gross Profit Margin
45.6%
46.6%
46.2%
47.3%
48.8%
R&D Expenses
-21.5
-22.3
-23.5
-24.5
-26.6
Selling, General & Admin Expenses
-2,061.8
-1,924.0
-2,044.9
-2,370.7
-2,617.8
Other Inc / (Exp)
12.3
17.2
23.5
24.5
26.6
Operating Expenses
-2,071.1
-1,929.2
-2,044.9
-2,370.7
-2,617.8
Operating Income
1,162.7
1,385.5
1,587.4
1,802.7
2,068.6
Net Interest Expenses
-104.4
-97.7
-88.6
-109.5
-95.0
EBT, Incl. Unusual Items
1,058.3
1,287.7
1,498.8
1,693.1
1,973.6
Earnings of Discontinued Ops.
-0.3
-
-
-
-
Income Tax Expense
-181.9
-176.8
-263.0
-345.1
-402.0
Net Income to Company
876.0
1,111.0
1,235.8
1,348.0
1,571.6
Minority Interest in Earnings
-
-
-
-
-
Net Income to Stockholders
876.0
1,111.0
1,235.8
1,348.0
1,571.6
Preferred Dividends & Other Adj.
-7.8
-7.6
-6.1
-5.5
-5.9
Net Income to Common Excl Extra Items
868.2
1,103.3
1,229.6
1,342.5
1,565.7
Basic EPS (Cont. Ops)
2.09
2.63
2.98
3.30
3.85
Diluted EPS (Cont. Ops)
2.03
2.56
2.91
3.25
3.79
Weighted Average Basic Shares Out.
415.3
419.5
412.7
406.6
406.6
Weighted Average Diluted Shares Out.
428.0
430.8
422.1
413.5
413.5
EBITDA
1,451.7
1,673.2
1,876.2
2,092.5
2,383.0
EBIT
1,171.9
1,390.6
1,587.4
1,802.7
2,068.6
Revenue (Reported)
7,085.1
7,116.3
7,854.5
8,815.8
9,596.6
Operating Income (Reported)
1,162.7
1,385.5
1,587.4
1,802.7
2,068.6
Operating Income (Adjusted)
1,171.9
1,390.6
1,587.4
1,802.7
2,068.6
FY-4FY-3FY-2FY-1FY01234
presentment in Millions except per share data. All rights reserved. Terms Of Use